In his State of the Union address, President Obama highlighted the important role of research and innovation in growing a more prosperous and healthier nation. We’re excited about the launch of the Precision Medicine Initiative, which comes at a time when the challenge of conquering disease – all along the research spectrum, from discovery to translation to innovation and application – has never been more within our grasp. The inspiring story of William Elder, Jr. a medical school student and cystic fibrosis survivor, shows that science can deliver breakthroughs for patients with cystic fibrosis, cancer, Alzheimer’s and other diseases. The remarkable ability of our nation’s researchers to advance precision medicine to hone targeted treatments to improve individual patient outcomes is a compelling example of what can be accomplished with federal support. We’re getting closer and closer to achieving treatments that save time, save money and save lives because they are right the first time.
We can’t afford to ease up on our commitment to research, to assure we can put a whole range of diseases in the history books. A further reason, noted by the President, is that we need robust funding and policies to ensure we’re not behind the eight ball addressing domestic or global outbreaks like Ebola. Current funding levels for federal health agencies put researchers at an extreme disadvantage in pursuing studies that have the potential to cure disease and improve quality of life, and tax policies have stymied the development of new drugs. Policymakers must pivot from short-sighted thinking to formulating a long-term strategy that will bring new treatments across the finish line and spur growth in quality jobs. We think it’s past time to adopt a national strategy that will assure the U.S. retains its world leadership in science and innovation. A new Blue Ribbon Commission established by Congress to explore how science is perceived by the public will help stimulate a meaningful conversation with Americans about the societal and economic benefits of science.
We hope that the compelling stories of William Elder, Jr. and the other guests of First Lady Michelle Obama will galvanize Congress as well as the President to boost funding for the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, National Science Foundation and Agency for Healthcare Research and Quality in his FY16 budget. We urge Congress to advance the 21st Century Cures initiative led by Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo.), and repeal sequestration, an ill-conceived deficit reduction strategy that continues to have serious ramifications on our nation’s research infrastructure. Americans deserve more from our elected officials if science and innovation are to have every opportunity to improve their health and economic security.